Addimmune is a startup based in unknown, most recent round Series-c-plus.
Addimmune is a company headquartered in unknown. Its most recent tracked round is Series-c-plus.
Develops gene and cell therapies to treat diseases, with a stated mission focused on developing therapies to cure or eliminate HIV.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.